VivoSeq
Other

Child

0

Pipeline Programs↗

7

Active Trials↗

2

Companies Involved↗

Child is an early-stage landscape with 0 programs across 2 companies. The most active players are Preventive Oncology International, Inc., Waymark.

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

91/100

Attrition Rate

5/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

P

Preventive Oncology International, Inc.

0 programs

PreclinicalW

Waymark

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

21

clinical trials

Completed10 · 48%
Recruiting6 · 29%
Unknown status3 · 14%
Terminated1 · 5%
Active, not recruiting1 · 5%

Clinical Trials

Trial Activity

21 trials

MDMA for Co-occurring PTSD and OUD After Childbirth
Recruiting·UUniversity of New Mexico·Phase 2·NCT05219175·15 enrolled
Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence
Recruiting·SShanghai Changzheng Hospital·Phase 2·NCT06078969·118 enrolled
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
Recruiting·PPharmaIN·Phase 1·NCT05490888·74 enrolled
Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
Recruiting·GGuangzhou 8th People's Hospital·N/A·NCT06947356·210 enrolled
Nutritional Care After Hospital Discharge (NutriCAD): A Stepped Wedged Multicentre Randomized Controlled Trial in Paediatrics
Recruiting·EErasmus Medical Center·Preclinical·NCT06414200·260 enrolled
A Center Based Early Intervention Program For Preschoolers With Developmental Disorders
Recruiting·SStanford University·Preclinical·NCT04026386·75 enrolled
Towards Implementation of the Pediatric Integrated Nutrition Pathway for Acute Care Pathway (P-INPAC) - Pilot Study
Active, not recruiting·TThe Hospital for Sick Children·N/A·NCT06645639·600 enrolled
The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru
Completed·PPreventive Oncology International, Inc.·Phase 1·NCT01338051·642 enrolled
Study of Dose-response to Bronchodilator and Dose-finding in Child 2.5 to 6 Years - Study Golden
Completed·AAssistance Publique - Hôpitaux de Paris·Phase 2·NCT01470755·90 enrolled
Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1
Completed·IInstitut de Recherche pour le Developpement·Phase 3·NCT00386230·1,554 enrolled
Childhood Adversity, Inflammatory Reactivity and Persistent Pain
Completed·UUniversity of Cape Town·N/A·NCT06127693·101 enrolled
Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00086359·19 enrolled
Short Therapy for Febrile UTI in Childhood
Completed·IIRCCS Burlo Garofolo·Phase 4·NCT04400110·154 enrolled
Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00074399·775 enrolled
Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
Completed·UUniversity of North Carolina, Chapel Hill·Phase 4·NCT00753324·284 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)